<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pereira MSF</submitter><funding>Nationwide Children's Hospital</funding><funding>NIH HHS</funding><pagination>705</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9913837</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(3)</volume><pubmed_abstract>Loss of cytotoxicity and defective metabolism are linked to glycogen synthase kinase 3 beta (GSK3β) overexpression in natural killer (NK) cells from patients with acute myeloid leukemia or from healthy donors after expansion ex vivo with IL-15. Drug inhibition of GSK3β in these NK cells improves their maturation and cytotoxic activity, but the mechanisms of GSK3β-mediated dysfunction have not been well studied. Here, we show that expansion of NK cells with feeder cells expressing membrane-bound IL-21 maintained normal GSK3β levels, allowing us to study GSK3β function using CRISPR gene editing. We deleted &lt;i>GSK3B&lt;/i> and expanded paired-donor knockout and wild-type (WT) NK cells and then assessed transcriptional and functional alterations induced by loss of GSK3β. Surprisingly, our data sh</pubmed_abstract><journal>Cancers</journal><pubmed_title>Deletion of Glycogen Synthase Kinase 3 Beta Reprograms NK Cell Metabolism.</pubmed_title><pmcid>PMC9913837</pmcid><funding_grant_id>AWD00001042</funding_grant_id><funding_grant_id>U54-CA232561</funding_grant_id><pubmed_authors>Maguire C</pubmed_authors><pubmed_authors>Naeimi Kararoudi M</pubmed_authors><pubmed_authors>Mundy-Bosse BL</pubmed_authors><pubmed_authors>Sorathia K</pubmed_authors><pubmed_authors>Thakkar A</pubmed_authors><pubmed_authors>Lee DA</pubmed_authors><pubmed_authors>Collins PL</pubmed_authors><pubmed_authors>Pereira MSF</pubmed_authors><pubmed_authors>Sezgin Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Deletion of Glycogen Synthase Kinase 3 Beta Reprograms NK Cell Metabolism.</name><description>Loss of cytotoxicity and defective metabolism are linked to glycogen synthase kinase 3 beta (GSK3β) overexpression in natural killer (NK) cells from patients with acute myeloid leukemia or from healthy donors after expansion ex vivo with IL-15. Drug inhibition of GSK3β in these NK cells improves their maturation and cytotoxic activity, but the mechanisms of GSK3β-mediated dysfunction have not been well studied. Here, we show that expansion of NK cells with feeder cells expressing membrane-bound IL-21 maintained normal GSK3β levels, allowing us to study GSK3β function using CRISPR gene editing. We deleted &lt;i>GSK3B&lt;/i> and expanded paired-donor knockout and wild-type (WT) NK cells and then assessed transcriptional and functional alterations induced by loss of GSK3β. Surprisingly, our data sh</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-25T19:25:01.9Z</modification><creation>2025-04-06T07:57:57.024Z</creation></dates><accession>S-EPMC9913837</accession><cross_references><pubmed>36765663</pubmed><doi>10.3390/cancers15030705</doi></cross_references></HashMap>